The COVID-19 Clinical Research Coalition is made up of institutions and individuals – from research centres, laboratories, and foundations to physicians, academics, and pharmacologists.
We’ve grown from our 77 original members to a coalition of more than 900. We’re working together to make sure that people in low-resource settings around the world are included in the global search for new COVID-19 treatments, diagnostics, and vaccines, with equal access to proven interventions.
Coalition members commit to:
- Accelerate COVID-19 research in areas where people are most at risk and have little access to existing treatments and vaccinations
- Leverage each other’s expertise to fast-track research that will provide evidence to guide policies and practices on COVID-19 prevention, diagnosis, and case management in resource-limited settings
- Promote and implement open sharing of research knowledge and data
- Champion equitable and affordable access to scientific advances
Apply to join the coalition!
Please fill out our short member application form. We particularly encourage institutions and individuals from in low- and middle-income countries to apply.
Discover coalition members
Please note that some members have requested not to be listed on the coalition’s website. Members listed with an asterisk are the 77 Lancet Comment signatories who participated in the COVID-19 Clinical Research Coalition launch.